Hugo A. Katus

171.3k total citations · 15 hit papers
1.4k papers, 59.1k citations indexed

About

Hugo A. Katus is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Surgery. According to data from OpenAlex, Hugo A. Katus has authored 1.4k papers receiving a total of 59.1k indexed citations (citations by other indexed papers that have themselves been cited), including 967 papers in Cardiology and Cardiovascular Medicine, 419 papers in Molecular Biology and 281 papers in Surgery. Recurrent topics in Hugo A. Katus's work include Cardiac electrophysiology and arrhythmias (254 papers), Cardiac Imaging and Diagnostics (237 papers) and Acute Myocardial Infarction Research (193 papers). Hugo A. Katus is often cited by papers focused on Cardiac electrophysiology and arrhythmias (254 papers), Cardiac Imaging and Diagnostics (237 papers) and Acute Myocardial Infarction Research (193 papers). Hugo A. Katus collaborates with scholars based in Germany, United States and United Kingdom. Hugo A. Katus's co-authors include Evangelos Giannitsis, Norbert Frey, Evangelos Giannitsis, Philippe Gabríel Steg, Robert F. Storey, Stefan James, Lars Wallentin, Andrew Remppis, Richard C. Becker and Steen Husted and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Hugo A. Katus

1.4k papers receiving 57.5k citations

Hit Papers

Ticagrelor versus Clopidogrel in Patient... 1991 2026 2002 2014 2009 2001 2002 1996 2009 1000 2.0k 3.0k 4.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
    2009 4.6k citations Lars Wallentin, Richard C. Becker et al. profile →
  2. Effect of Carvedilol on Survival in Severe Chronic Heart Failure
    2001 2.2k citations Hugo A. Katus et al. profile →
  3. Effect of Carvedilol on the Morbidity of Patients With Severe Chronic Heart Failure
    2002 928 citations Hugo A. Katus et al. Circulation profile →
  4. Cardiac Troponin T Levels for Risk Stratification in Acute Myocardial Ischemia
    1996 859 citations Hugo A. Katus, Christian W. Hamm et al. profile →
  5. Analytical Validation of a High-Sensitivity Cardiac Troponin T Assay
    2009 838 citations Evangelos Giannitsis, Hugo A. Katus et al. profile →
  6. The Prognostic Value of Serum Troponin T in Unstable Angina
    1992 724 citations Christian W. Hamm, Hugo A. Katus et al. profile →
  7. Hypertrophy of the Heart
    2004 673 citations Norbert Frey, Hugo A. Katus et al. Circulation profile →
  8. Diagnostic efficiency of troponin T measurements in acute myocardial infarction.
    1991 632 citations Hugo A. Katus, Andrew Remppis et al. Circulation profile →
  9. Effect of CYP2C19 and ABCB1 single nucleotide polymorphisms on outcomes of treatment with ticagrelor versus clopidogrel for acute coronary syndromes: a genetic substudy of the PLATO trial
    2010 582 citations Lars Wallentin, Stefan James et al. profile →
  10. High-Mobility Group Box-1 in Ischemia-Reperfusion Injury of the Heart
    2008 527 citations Martin Andrassy, H. Christian Volz et al. Circulation profile →
  11. How to use high-sensitivity cardiac troponins in acute cardiac care
    2012 523 citations Evangelos Giannitsis, Christian W. Hamm et al. profile →
  12. Recommendations for the use of cardiac troponin measurement in acute cardiac care
    2010 457 citations Hugo A. Katus, Bertil Lindahl et al. profile →
  13. Troponin elevation in coronary vs. non-coronary disease
    2010 456 citations Evangelos Giannitsis, Hugo A. Katus et al. profile →
  14. Comparison of ticagrelor with clopidogrel in patients with a planned invasive strategy for acute coronary syndromes (PLATO): a randomised double-blind study
    2010 436 citations Stefan James, Richard C. Becker et al. profile →
  15. ST-segment elevation myocardial infarction
    2019 234 citations Evangelos Giannitsis, Hugo A. Katus et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hugo A. Katus Germany 106 38.5k 16.2k 11.9k 9.1k 4.5k 1.4k 59.1k
David A. Morrow United States 100 29.5k 0.8× 4.1k 0.3× 12.8k 1.1× 9.2k 1.0× 5.0k 1.1× 592 45.0k
James T. Willerson United States 101 21.0k 0.5× 9.3k 0.6× 16.9k 1.4× 8.2k 0.9× 6.0k 1.3× 631 47.8k
Scott D. Solomon United States 140 64.9k 1.7× 9.0k 0.6× 13.5k 1.1× 9.9k 1.1× 7.3k 1.6× 1.2k 93.2k
Eugene Braunwald United States 104 43.0k 1.1× 4.5k 0.3× 20.7k 1.7× 12.5k 1.4× 4.2k 0.9× 448 59.7k
Allan S. Jaffe United States 99 38.7k 1.0× 4.1k 0.3× 13.6k 1.1× 13.9k 1.5× 3.9k 0.9× 622 51.4k
Michael Böhm Germany 119 37.8k 1.0× 11.9k 0.7× 14.1k 1.2× 3.0k 0.3× 3.2k 0.7× 1.1k 61.6k
Michael C. Fishbein United States 102 15.9k 0.4× 7.5k 0.5× 11.4k 1.0× 4.5k 0.5× 3.3k 0.7× 641 37.2k
Amir Lerman United States 107 27.2k 0.7× 8.0k 0.5× 15.0k 1.3× 11.0k 1.2× 3.4k 0.8× 881 51.0k
Thomas F. Lüscher Switzerland 127 28.1k 0.7× 11.6k 0.7× 13.6k 1.1× 6.0k 0.7× 4.4k 1.0× 1.1k 62.6k
Lina Badimón Spain 86 13.8k 0.4× 7.8k 0.5× 11.7k 1.0× 3.5k 0.4× 3.6k 0.8× 700 35.1k

Countries citing papers authored by Hugo A. Katus

Since Specialization
Citations

This map shows the geographic impact of Hugo A. Katus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hugo A. Katus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hugo A. Katus more than expected).

Fields of papers citing papers by Hugo A. Katus

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hugo A. Katus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hugo A. Katus. The network helps show where Hugo A. Katus may publish in the future.

Co-authorship network of co-authors of Hugo A. Katus

This figure shows the co-authorship network connecting the top 25 collaborators of Hugo A. Katus. A scholar is included among the top collaborators of Hugo A. Katus based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hugo A. Katus. Hugo A. Katus is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ochs, Andreas, Janek Salatzki, Lukas D. Weberling, et al.. (2025). Dynamic handgrip exercise for the detection of myocardial ischemia using fast Strain-ENCoded cardiovascular magnetic resonance. Journal of Cardiovascular Magnetic Resonance. 27(1). 101879–101879. 1 indexed citations
2.
Hund, Hauke, et al.. (2025). Outcomes and Disease Management in Patients With Atrial Fibrillation ≥80 Years: Data From a Consecutive 11‐Year Real‐World Registry. Journal of the American Heart Association. 14(4). e036832–e036832.
3.
Seitz, Andreas, Martin Busch, Stéphanie Simon, et al.. (2024). S100A1’s single cysteine is an indispensable redox switch for the protection against diastolic calcium waves in cardiomyocytes. American Journal of Physiology-Heart and Circulatory Physiology. 327(1). H275–H286. 3 indexed citations
4.
Hjort, Marcus, Kai M. Eggers, Tatevik Ghukasyan Lakic, et al.. (2022). Biomarker Concentrations and Their Temporal Changes in Patients With Myocardial Infarction and Nonobstructive Compared With Obstructive Coronary Arteries: Results From the PLATO Trial. Journal of the American Heart Association. 12(1). e027466–e027466. 18 indexed citations
5.
Elliott, Perry, Martín Cowie, Jennifer Franke, et al.. (2020). Development, validation, and implementation of biomarker testing in cardiovascular medicine state-of-the-art: proceedings of the European Society of Cardiology—Cardiovascular Round Table. Cardiovascular Research. 117(5). 1248–1256. 13 indexed citations
6.
Katus, Hugo A., et al.. (2020). Cochrane corner: NOACs in atrial fibrillation patients post-percutaneous coronary intervention. Heart. 106(17). 1293–1295. 1 indexed citations
7.
Geis, Nicolas A., Florian Leuschner, Benjamin Meder, et al.. (2018). Periprocedural antibiotic treatment in transvascular aortic valve replacement. Journal of Interventional Cardiology. 31(6). 885–890. 6 indexed citations
8.
Appari, Mahesh, Astrid Breitbart, Florian Brandes, et al.. (2016). C1q-TNF-Related Protein-9 Promotes Cardiac Hypertrophy and Failure. Circulation Research. 120(1). 66–77. 78 indexed citations
9.
Kreußer, Michael M., Lorenz Lehmann, Stanislav Keranov, et al.. (2014). Cardiac CaM Kinase II Genes δ and γ Contribute to Adverse Remodeling but Redundantly Inhibit Calcineurin-Induced Myocardial Hypertrophy. Circulation. 130(15). 1262–1273. 133 indexed citations
10.
Lehmann, Lorenz, Sebastian J. Buss, Michael M. Kreußer, et al.. (2014). Essential role of sympathetic endothelin A receptors for adverse cardiac remodeling. Proceedings of the National Academy of Sciences. 111(37). 13499–13504. 20 indexed citations
11.
Hassel, David, Paul Cheng, Mark P. White, et al.. (2012). MicroRNA-10 Regulates the Angiogenic Behavior of Zebrafish and Human Endothelial Cells by Promoting Vascular Endothelial Growth Factor Signaling. Circulation Research. 111(11). 1421–1433. 64 indexed citations
12.
Wallentin, Lars, Stefan James, Evangelos Giannitsis, et al.. (2012). Abstract 15929: Outcomes with Ticagrelor Versus Clopidogrel in Relation to High Sensitivity Troponin-T in Non-ST-Elevation Acute Coronary Syndrome Patients Managed with Early Invasive or Non-Invasive Treatment - A Substudy from the Prospective Randomized PLATelet Inhibition and Patient Outcomes (PLATO) Trial. Circulation. 126. 3 indexed citations
13.
Volz, H. Christian, Sebastian J. Buss, Jin Li, et al.. (2011). Autoimmunity Against Cardiac Troponin I in Ischaemia Reperfusion Injury. European Journal of Heart Failure. 13(10). 1052–1059. 15 indexed citations
14.
Meder, Benjamin, Jan Haas, Andreas Keller, et al.. (2011). Targeted Next-Generation Sequencing for the Molecular Genetic Diagnostics of Cardiomyopathies. Circulation Cardiovascular Genetics. 4(2). 110–122. 117 indexed citations
15.
Seeger, Thalia S., Derk Frank, Claudia M. Rohr, et al.. (2010). Myozap, a Novel Intercalated Disc Protein, Activates Serum Response Factor–Dependent Signaling and Is Required to Maintain Cardiac Function In Vivo. Circulation Research. 106(5). 880–890. 45 indexed citations
16.
Chorianopoulos, Emmanuel, et al.. (2009). Decreased Soluble TWEAK Levels Predict an Adverse Prognosis in Patients with Chronic Stable Heart Failure. European Journal of Heart Failure. 11(11). 1050–1056. 61 indexed citations
17.
Hippe, Hans‐Joerg, Nadine M. Wolf, Issam Abu-Taha, et al.. (2009). The interaction of nucleoside diphosphate kinase B with Gβγ dimers controls heterotrimeric G protein function. Proceedings of the National Academy of Sciences. 106(38). 16269–16274. 54 indexed citations
18.
Pleger, Sven T., Patrick Most, Matthieu Boucher, et al.. (2007). Stable Myocardial-Specific AAV6-S100A1 Gene Therapy Results in Chronic Functional Heart Failure Rescue. Circulation. 115(19). 2506–2515. 139 indexed citations
19.
Weichenhan, Dieter, et al.. (2006). Fine mapping of Dyscalc1, the major genetic determinant of dystrophic cardiac calcification in mice. Physiological Genomics. 25(3). 387–392. 12 indexed citations
20.
Mereles, Derliz, Nicola Ehlken, Sedigheh Ghofrani, et al.. (2006). Exercise and Respiratory Training Improve Exercise Capacity and Quality of Life in Patients With Severe Chronic Pulmonary Hypertension. Circulation. 114(14). 1482–1489. 466 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David A. Morrow Breakdown of academic impact, for papers by James T. Willerson Breakdown of academic impact, for papers by Scott D. Solomon Breakdown of academic impact, for papers by Eugene Braunwald Breakdown of academic impact, for papers by Allan S. Jaffe Breakdown of academic impact, for papers by Michael Böhm Breakdown of academic impact, for papers by Michael C. Fishbein Breakdown of academic impact, for papers by Amir Lerman Breakdown of academic impact, for papers by Thomas F. Lüscher Breakdown of academic impact, for papers by Lina Badimón
Rankless by CCL
2026